Medical Equipment

Immunohistochemistry (IHC) Market Analysis 2025–2029: Growth Forecast and Competitive Insights

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the immunohistochemistry (ihc) market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Immunohistochemistry (IHC) Market Be Worth By 2029, And What CAGR Will It Achieve?

The immunohistochemistry (ihc) market has experienced strong expansion in recent years. It is projected to increase from $2.58 billion in 2024 to $2.76 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.2%. The growth observed in prior periods can be attributed to factors such as widespread clinical adoption, efforts towards industry standardization, significant expansion in cancer research, increased automation in laboratories, and continuous advancements in clinical diagnostics.

The immunohistochemistry (ihc) market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to climb to $4.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.2%. This anticipated increase over the forecast period is driven by factors such as the arrival of new market entrants, increasing demand in drug development, the incorporation of biomedical research, diverse diagnostic applications, and the progression of automation and digitalization. Prominent trends expected in this period involve multiplex IHC techniques, the integration of digital pathology, improved antibody specificity, greater automation and standardization, and its use in biomarker discovery.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Which Factors Are Driving The Immunohistochemistry (IHC) Market Forward?

A rise in the occurrence of chronic illnesses is anticipated to drive the immunohistochemistry (IHC) market in the future. These conditions are defined as medical ailments persisting for at least three months, typically manageable but not curable. Immunohistochemistry aids in the diagnosis of such conditions, including cancer and cardiovascular disorders, leveraging its benefits like specificity, sensitivity (for identifying particular antigens), and quick outcomes. For example, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that approximately 37.3 million individuals, representing 11.3% of the United States population, had diabetes in 2022. Consequently, the growing incidence of chronic diseases is fueling the expansion of the immunohistochemistry (IHC) market.

Which Segments Form The Key Structure Of The Immunohistochemistry (IHC) Market?

The immunohistochemistry (ihc)market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

What Strategic Shifts And Innovations Are Influencing The Immunohistochemistry (IHC) Market?

Leading firms within the immunohistochemistry (IHC) market are concentrating on improving diagnostic precision by utilizing cutting-edge technologies and superior reagents, thereby boosting the efficiency of tissue analysis across diverse clinical and research settings. The Neoflex multiomics mass spectrometry imaging (MSI) system stands as a sophisticated imaging platform, purpose-built for accurate tissue analysis. It facilitates researchers’ progress from initial discovery stages to clinical applications, leveraging high-resolution mass spectrometry methods, especially for the spatial mapping of biomolecules within tissues. As an example, in June 2024, Bruker Corporation, a US-based entity specializing in the development and production of scientific instruments as well as analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler, intended for mass spectrometry-based tissue imaging. This Neoflex multiomics mass spectrometry imaging (MSI) system is designed to meet the imperative of moving beyond discovery imaging into clinical tissue research. Key features include Bruker’s 10-kHz smartbeam 3D laser, improved imaging detectors, and compatibility with OME-TIFF file output when used with SCiLS Scope software.

Which Firms Are Making The Biggest Impact In The Immunohistochemistry (IHC) Market?

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Which Region Is Expected To Lead The Immunohistochemistry (IHC) Market In The Next Few Years?

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795